Project description
How age affects cancer outcomes
Millions of people around the world are diagnosed with cancer each year, with older adults accounting for the highest number of diagnoses – a number that is expected to double in the future. Older-aged cancer patients do not benefit from the improvements in cancer diagnosis and treatment in the same way as those who are middle-aged. Such disparities have a detrimental effect on their lives. Shedding light on this, the EU-funded ISAC project will investigate the role of comorbidities and other factors in cancer survival disparities between older and younger patients. The findings of the project will assist interventions to increase the probability of survival regardless of age.
Objective
Cancer patients are increasingly surviving their disease, but disparities in cancer outcomes still persist, and even widen, for some groups of patients. This is the case for older adults as they have not benefitted from the improvements in cancer diagnosis and treatment at the same magnitude as their middle-aged counterparts. Older adults account for the largest proportion of cancer diagnoses, and with the number of diagnoses expected to double in two decades such disparities will result in substantial amount of years of life lost due to unfair age-related disparities in cancer survival. The ISAC project thus aims to investigate the role of comorbidities and other factors in cancer survival disparities among older patients compared with younger patients, which will aid interventions to increase the probability of survival regardless of age. Dr Sophie Pilleron will have the opportunity to be trained at the highest possible level, extending her knowledge in comorbidities and health disparities research in the University of Otago, and her knowledge in colon and lung cancer in the THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD. She will also extend her transferable skills (e.g. grant writing, oral communication, and student supervision), which are necessary for a successful career as an independent researcher. Finally, the results of the ISAC project will be disseminated and communicated to the scientific community, policy makers and the general public through a range of activities. For example, the findings of the project will be disseminated through high-impact publications and presentations at international conferences, and the Fellow will directly present her research to policy makers. She will also target non-specialists through media outlets, social networking services, online videos, or presentations at science festivals in order to facilitate the translation of the findings and their related implications to a non-scientific audience.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
You need to log in or register to use this function
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.1.3. - EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.1.3.2. - Nurturing excellence by means of cross-border and cross-sector mobility
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
MSCA-IF-GF - Global Fellowships
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-MSCA-IF-2018
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
OX1 2JD Oxford
United Kingdom
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.